| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNF receptor superfamily member 8 | 0.444 | 0.808 | 0.86 |
|
disease | 0.400 | None | 0.991 | 5 | 0 | 1987 | 2020 | ||||||||
|
BCL3 transcription coactivator | 0.541 | 0.731 | 0.99 |
|
disease | 0.090 | None | 1.000 | 4 | 0 | 1994 | 2008 | ||||||||
|
Spi-1 proto-oncogene | 0.631 | 0.654 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2005 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
disease | 0.550 | None | 1.000 | 3 | 0 | 2001 | 2010 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.100 | None | 0.944 | 3 | 0 | 1994 | 2018 | ||||||||
|
suppressor of cytokine signaling 1 | 0.445 | 0.808 | 0.59 |
|
disease | 0.340 | None | 1.000 | 3 | 0 | 2006 | 2009 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
galectin 1 | 0.435 | 0.846 | 4.5E-03 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2000 | 2007 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.070 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
inhibitor of DNA binding 2 | 0.572 | 0.731 | 0.67 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.917 | 2 | 0 | 1994 | 2007 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.965 | 2 | 0 | 1987 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.957 | 2 | 0 | 1991 | 2019 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2000 | 2007 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
signal transducer and activator of transcription 6 | 0.475 | 0.808 | 0.99 |
|
disease | 0.070 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
CASP8 and FADD like apoptosis regulator | 0.485 | 0.846 | 1.00 |
|
disease | 0.360 | None | 1.000 | 2 | 0 | 2003 | 2008 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1995 | 2008 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.100 | None | 0.913 | 2 | 0 | 1992 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.040 | None | 0.750 | 2 | 0 | 2002 | 2018 | ||||||||
|
basigin (Ok blood group) | 0.458 | 0.769 | 2.6E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
POU class 2 homeobox associating factor 1 | 0.608 | 0.615 | 0.57 |
|
disease | 0.130 | None | 1.000 | 1 | 0 | 2001 | 2018 |